Advocacy
CBD, Tobacco, Pesticides & Parkinson’s
Is there a relationship between smoking, pesticides, and Parkinson’s?
November 13, 2019
No Comments
Is there a relationship between smoking, pesticides, and Parkinson’s?
The MJFF states their support for medical cannabis research and reform.
An elderly woman suffering from Parkinson’s Disease who was prescribed medical marijuana by her physician was denied her medication by the staff of her nursing home.
Parkinson’s disease has been in the news a lot lately with the passing of boxing legend, and social justice icon, Muhammad Ali. Muhammad Ali had
By Paul Armentano, NORML Deputy Director The administration of cannabidiol (CBD), a nonpsychotropic cannabinoid, is associated with improved quality of life in patients with Parkinson’s
Courtesy of The Joint Blog A new study published in the British Journal of Pharmacology has found that cannabis may treat neurodegenerative diseases such as Alzheimer’s disease. “In an
By Paul Armentano, NORML Deputy Director Inhaling whole-plant cannabis provides symptomatic relief in patients with Parkinson’s disease (PD), according to observational trial data published in the March/April
Courtesy of The Joint Blog According to a study being published in next month’s issue of the Journal of Neurology, Neurosurgery & Psychiatry, and published online early by the National Institute of health, has
Courtesy of The Joint Blog A new study funded by the National Institute for Translational Medicine, and published in last month’s issue of the journal Molecular Neurobuology, has found that cannabis may
Courtesy of The Joint Blog Researchers have discovered that smoking cannabis can reduce symptoms of Parkinson’s disease, including tremors and pain. 20 patients, at an average of
The Panel recommends Post-traumatic Stress Disorder and Parkinson’s Disease be added to Michigan’s medical marijuana conditions LANSING- On Friday April 5 a panel of doctors gave
Michigan Conditions Panel Recommends Marijuana Use For Parkinson’s, Asks For More Info On PTSD By Rick Thompson A long-awaited panel was convened in Lansing on
Cannabis’ active components show promise in halting the progression of certain neurodegerative disorders and should be evaluated in clinical trials, according to a review published